Search
for

    Glossary Radical Prostatectomy

    surgical removal of the prostate gland to treat cancer

    Radical Prostatectomy is a surgical procedure that involves the complete removal of the prostate gland and some of the surrounding tissue, typically to treat prostate cancer. This surgery aims to eliminate cancerous cells and prevent the spread of the disease, and it can be performed using various techniques, including open surgery, laparoscopic surgery, or robot-assisted surgery.

    Related Terms

    Sort by

    Research 30 of 1000+

    1. What are the possible reasons for urethral PSA varieties after radical prostatectomy? Acta Chirurgica Iugoslavica · 2010 · 5 citations
    2. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy The Journal of Urology · 2024 · 4 citations
    3. S5 IS THE RADICAL PROSTATECTOMY THE BEST CHOICE FOR PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER? European Urology Supplements · 2010
    4. S4 URETHRAL PSA LEVELS AFTER RADICAL PROSTATECTOMY European Urology Supplements · 2010
    5. S90 Urethral PSA production after radical prostatectomy European Urology Supplements · 2009
    6. DOES PSADT AFTER RADICAL PROSTATECTOMY PREDICT OVERALL SURVIVAL?—A REPORT FROM THE SEARCH DATABASE GROUP The Journal of Urology · 2009
    7. A Chance Finding of High Grade Prostate Cancer in a 35-Year-Old Male – A Case Report and Outcomes of Robotic Radical Prostatectomy in Young Men with Prostate Cancer Research and reports in urology · 2023
    8. Patient reported androgen driven phenotypes do not associate with biochemical recurrence after radical prostatectomy UTUPub (University of Turku) · 2020
    9. Common urologic diseases in older men and their treatment: how they impact fertility Fertility and Sterility · 2017 · 8 citations
    10. S2 PSA: RELIABLE OR NOT RELIABLE? European Urology Supplements · 2010
    11. Urological Oncology: Prostate Cancer The Journal of Urology · 2008
    12. Intervention beim PCa: leichte Pluspunkte für radikale Prostatektomie Uro-News · 2012
    13. 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER The Journal of Urology · 2012
    14. Gleason grading controversies: what the chemoprevention trials have taught us Canadian Urological Association Journal · 2013 · 4 citations
    15. 311 Novel Penile Ultrasound Technique to Explain Mechanism of Erectile Dysfunction (ED) in Young Patients using Finasteride for Androgenic Alopecia The Journal of Sexual Medicine · 2018 · 1 citations
    16. Prostate cancer risk and recurrence: the role of nutrition and clinical aspects 2013
    17. S1 OPIOID RECEPTOR AGONISTS AND SERUM PROSTATE SPECIFIC ANTIGENE LEVEL: IS THERE A ROLE FOR PROSTATE CANCER CONTROL AND CHEMOPREVENTION? European Urology Supplements · 2010
    18. The Use of Stromal Vascular Fraction in the Treatment of Male Sexual Dysfunction: A Review of Preclinical and Clinical Studies Sexual medicine reviews · 2018 · 11 citations
    19. Prostate cancer update: 2007 Current Opinion in Oncology · 2008 · 6 citations
    20. Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem) Reports of Practical Oncology & Radiotherapy · 2020 · 4 citations
    21. Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers Cancers · 2022 · 10 citations
    22. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    23. Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells The Journal of Urology · 2008 · 25 citations
    24. Current Literature Review The Journal of Sexual Medicine · 2013
    25. Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships Current Medicinal Chemistry · 2000 · 204 citations
    26. Recent discoveries and developments of androgen receptor based therapy for prostate cancer MedChemComm · 2015 · 17 citations
    27. 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice European Urology · 2013 · 7 citations
    28. Optimized Nanostructured Lipid Carriers for Dutasteride Delivery: Improving Therapeutic Efficiency and Minimizing Adverse Effects International Journal of Drug Delivery Technology · 2024
    29. Table of Contents Sexual medicine reviews · 2019
    30. IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER The Journal of Urology · 2009